Financials

News Discussions Technicals Seasonals

ALECR fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Eurofins-Cerep SA engages in the provision of preclinical drug research services. The firm’s BioPrint, allows the modeling of clinical effects of drug candidates from molecular properties. Its services include compound management, high-throughput screening, in vitro safety profiling, assay development, and profile design. The company was founded on December 20, 1989 and is headquartered in Celle l'Evescault, France.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

ALECR does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company